Skip links

Multinational forum on stem cell therapy for COVID-19 treatment in Asia- BIO Asia Taiwan 2021

In conjunction with BioAsia Conference, 21st to 25th July 2021, in which this year will be held in Taiwan, we are organizing webinar title – Advanced Cell Therapies for COVID-19 Pandemic/post-Pandemic Applications.

 

This webinar also listed as one of the agenda in the Satellite Conference during BioAsia Taiwan. (https://bioasiataiwan.com/en)

 

Sincerely invite you to join us online on 21st July at 15:40-17:40 (UTC+8) for this multinational forum on stem cell therapy for COVID-19 treatment in Asia. Key experts from 6 countries will share their clinical experience. Free to register.

 

Registration link: https://pse.is/3kdwul

 

We encourage early registration to get the access link.

 

新冠肺炎爆發後,細胞治療也百倍速前進,短短18個月,全球已有77國投入間質幹細胞(MSC)治療新冠肺炎的臨床研究,臨床試驗案更高達348項。亞洲受變異株影響,印尼、馬來西亞、泰國等國家每日確診數激增8~10倍,面對居高不下的致死率,各國紛紛尋求突破性治療,泰國、台灣為此進行間質幹細胞恩慈療法,印尼亦為細胞治療提交緊急使用授權(EUA)申請。生技產業為此舉辦「細胞治療於疫情/後疫情時代之臨床應用」國際學術論壇,透過7/21 BIO Asia–Taiwan線上衛星演講平台,與醫界交流、分享第一手臨床經驗。

 

如欲閱讀完整內容,請至中時新聞網:https://www.chinatimes.com/realtimenews/20210715003766-260508?from=copy